Boston Scientific Debt to Equity Ratio 2006-2019 | BSX

Current and historical debt to equity ratio values for Boston Scientific (BSX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Boston Scientific debt/equity for the three months ending June 30, 2019 was 0.81.
Boston Scientific Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-06-30 $7.59B $9.42B 0.81
2019-03-31 $7.59B $9.23B 0.82
2018-12-31 $4.80B $8.73B 0.55
2018-09-30 $4.81B $8.29B 0.58
2018-06-30 $4.81B $7.74B 0.62
2018-03-31 $4.80B $7.03B 0.68
2017-12-31 $3.82B $7.01B 0.54
2017-09-30 $4.42B $7.59B 0.58
2017-06-30 $4.82B $7.24B 0.67
2017-03-31 $5.51B $7.05B 0.78
2016-12-31 $5.42B $6.73B 0.81
2016-09-30 $5.17B $6.48B 0.80
2016-06-30 $5.17B $6.22B 0.83
2016-03-31 $5.42B $6.46B 0.84
2015-12-31 $5.67B $6.32B 0.90
2015-09-30 $5.80B $6.41B 0.90
2015-06-30 $5.07B $6.58B 0.77
2015-03-31 $3.85B $6.50B 0.59
2014-12-31 $3.84B $6.46B 0.60
2014-09-30 $4.25B $6.70B 0.63
2014-06-30 $4.25B $6.54B 0.65
2014-03-31 $4.25B $6.53B 0.65
2013-12-31 $4.24B $6.54B 0.65
2013-09-30 $4.25B $6.56B 0.65
2013-06-30 $3.65B $6.60B 0.55
2013-03-31 $4.25B $6.50B 0.65
2012-12-31 $4.25B $6.87B 0.62
2012-09-30 $4.25B $6.83B 0.62
2012-06-30 $4.25B $7.73B 0.55
2012-03-31 $4.26B $11.40B 0.37
2011-12-31 $4.26B $11.35B 0.38
2011-09-30 $4.26B $11.52B 0.37
2011-06-30 $4.20B $11.54B 0.36
2011-03-31 $4.67B $11.37B 0.41
2010-12-31 $4.93B $11.30B 0.44
2010-09-30 $5.13B $11.04B 0.47
2010-06-30 $5.18B $10.89B 0.48
2010-03-31 $5.67B $10.78B 0.53
2009-12-31 $5.92B $12.30B 0.48
2009-09-30 $5.77B $13.30B 0.43
2009-06-30 $5.92B $13.41B 0.44
2009-03-31 $6.24B $13.28B 0.47
2008-12-31 $6.74B $13.17B 0.51
2008-09-30 $6.77B $15.69B 0.43
2008-06-30 $7.01B $15.64B 0.45
2008-03-31 $7.31B $15.39B 0.48
2007-12-31 $7.93B $15.10B 0.53
2007-09-30 $7.90B $15.52B 0.51
2007-06-30 $8.25B $15.80B 0.52
2007-03-31 $8.90B $15.55B 0.57
2006-12-31 $8.90B $15.30B 0.58
2006-09-30 $8.89B $15.02B 0.59
2006-06-30 $8.89B $14.89B 0.60
2006-03-31 $1.84B $4.67B 0.39
2005-12-31 $1.86B $4.28B 0.44
2005-09-30 $2.43B $3.90B 0.62
2005-06-30 $1.52B $4.22B 0.36
2005-03-31 $1.12B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $53.253B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.337B 20.26
Abbott Laboratories (ABT) United States $140.738B 26.45
Stryker (SYK) United States $79.987B 27.66
Baxter (BAX) United States $44.944B 27.25
EssilorLuxottica Societe Anonyme (ESLOY) France $32.375B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.013B 17.93
Coloplast (CLPBY) Denmark $24.818B 39.62
Lonza Group Ag (LZAGY) Switzerland $24.634B 0.00
Terumo (TRUMY) Japan $23.332B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.543B 0.00
ResMed (RMD) United States $18.641B 35.52
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.871B 52.91
Insulet (PODD) United States $9.245B 547.82
Perrigo (PRGO) Ireland $7.271B 13.39
Canopy Growth (CGC) Canada $6.759B 0.00
Hill-Rom Holdings (HRC) United States $6.636B 19.78
Haemonetics (HAE) United States $6.525B 49.24
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Neogen (NEOG) United States $3.350B 56.05
NuVasive (NUVA) United States $3.316B 26.44
ICU Medical (ICUI) United States $3.170B 20.56
Quidel (QDEL) United States $2.389B 23.72
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.290B 0.00
Agios Pharmaceuticals (AGIO) United States $1.917B 0.00
National Vision Holdings (EYE) United States $1.879B 40.56
Cardiovascular Systems (CSII) United States $1.641B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.080B 24.88
AtriCure (ATRC) United States $1.009B 0.00
Phibro Animal Health (PAHC) United States $0.855B 13.90
Eagle Pharmaceuticals (EGRX) United States $0.821B 20.92
Omeros (OMER) United States $0.756B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Lantheus Holdings (LNTH) United States $0.737B 19.38
PetIQ (PETQ) United States $0.712B 16.81
Cerus (CERS) United States $0.630B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.86
Surmodics (SRDX) United States $0.573B 109.00
MacroGenics (MGNX) United States $0.556B 0.00
Quanterix (QTRX) United States $0.547B 0.00
TG Therapeutics (TGTX) United States $0.493B 0.00
OraSure Technologies (OSUR) United States $0.475B 22.00
Owens & Minor (OMI) United States $0.399B 11.94
Meridian Bioscience (VIVO) United States $0.382B 11.93
Zynex (ZYXI) United States $0.379B 40.31
Utah Medical Products (UTMD) United States $0.347B 25.45
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.311B 0.00
BioLife Solutions (BLFS) United States $0.309B 95.06
United Health Products (UEEC) United States $0.245B 0.00
Bovie Medical (APYX) United States $0.235B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.160B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.128B 9.00
InfuSystems Holdings (INFU) United States $0.128B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.085B 20.14
Nephros (NEPH) United States $0.071B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.034B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00